Abbvie Inc. vs Canopy Growth Corporation
ABBV vs CGC — side-by-side comparison from reported financials. ABBV leads 8, CGC leads 1 of 9 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Canopy Growth Corporation
CGC · Healthcare
$0.84-0.80%Mixed
| Metric | ABBV | CGC |
|---|---|---|
| Price | $276.43 | $0.84 |
| Market cap | $488B | $360M |
| Revenue (TTM) | $64.4B | $285M |
| Revenue growth | +1.8% | -10.9% |
| Net margin | 9.8% | -92.4% |
| Free cash flow | $18.2B | -$69.1M |
| Net cash (debt) | ($56.2B) | $148M |
| 1-year price return | +19.8% | -49.1% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | — |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -33% |
| Altman Z-score | 2.33 | -13.41 |
| CV checks passed | 9 of 11 | 3 of 11 |
| Employees | 57,000 | 1,128 |
Full résumé-style profiles: ABBV CV · CGC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.